Hereditary hemorrhagic telangiectasia]. Rev Prat, pp.899-903, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00443253
Trente ans d'??tude de la maladie de Rendu-Osler en France??: d??mographie historique, g??n??tique des populations et biologie mol??culaire, Population, vol.64, issue.2, pp.305-330, 2009. ,
DOI : 10.3917/popu.902.0305
Endoglin, a TGF-?? binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1, Nature Genetics, vol.23, issue.4, pp.345-51, 1994. ,
DOI : 10.1101/gr.2.3.234
A third locus for hereditary haemorrhagic telangiectasia maps to chromosome 12q, Human Molecular Genetics, vol.4, issue.5, pp.945-954, 1995. ,
DOI : 10.1093/hmg/4.5.945
Molecular defects in rare bleeding disorders: hereditary haemorrhagic telangiectasia, Thromb Haemost, vol.78, issue.1, pp.145-50, 1997. ,
Rendu-Osler disease: clinical and molecular update]. Médecine Sci MS, pp.855-60, 2010. ,
Hereditary hemorrhagic telangiectasia]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, pp.21-28, 2014. ,
Pulmonary Vascular Manifestations of Hereditary Hemorrhagic Telangiectasia (Rendu-Osler Disease), Respiration, vol.31, issue.4, pp.361-78, 2007. ,
DOI : 10.1111/j.1365-2796.2005.01555.x
Genotypephenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations, Am J Med Genet A, vol.140, issue.5, pp.463-70, 2006. ,
DOI : 10.1002/ajmg.a.31101
Liver involvement in hereditary hemorrhagic telangiectasia], Acta Gastroenterol Latinoam, vol.41, issue.3, pp.225-234, 2011. ,
Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab, Annals of Hematology, vol.90, issue.9, pp.631-633, 2006. ,
DOI : 10.1007/s00277-006-0147-8
Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: Effectiveness of an injection protocol based on the vascular anatomy of the nose, The Laryngoscope, vol.268, issue.6, 2012. ,
DOI : 10.1007/s00405-011-1677-9
Iron Deficiency Anemia Related to Hereditary Hemorrhagic Telangiectasia: Response to Treatment With Bevacizumab, The American Journal of the Medical Sciences, vol.343, issue.3, pp.249-51, 2012. ,
DOI : 10.1097/MAJ.0b013e3182429866
Efficacy of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis. The Laryngoscope, pp.636-644, 2011. ,
Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output, JAMA, vol.307, issue.9, pp.948-55, 2012. ,
DOI : 10.1001/jama.2012.250
Hemodynamics Should Be the Primary Approach to Diagnosing, Following, and Managing Pulmonary Arterial Hypertension, Canadian Journal of Cardiology, vol.31, issue.4, 2014. ,
DOI : 10.1016/j.cjca.2014.09.021
Updated Clinical Classification of Pulmonary Hypertension, J Am Coll Cardiol, vol.62, pp.25-34, 2013. ,
[Pulmonary hypertension: definition, diagnostic and new classification]. Presse Médicale Paris Fr 1983, pp.935-979, 2014. ,
Echocardiography and right heart catheterization in pulmonal hypertension], Dtsch Med Wochenschr, vol.139, issue.30, pp.1511-1518, 1946. ,
Factors influencing the echocardiographic estimate of right ventricular systolic pressure in normal patients and clinically relevant ranges according to age, Canadian Journal of Cardiology, vol.26, issue.2, pp.35-44, 2010. ,
DOI : 10.1016/S0828-282X(10)70004-0
Traitement de l'hypertension artérielle pulmonaire. Presse Médicale, pp.981-93, 2014. ,
Pulmonary Hypertension Due to Left Heart Diseases, Journal of the American College of Cardiology, vol.62, issue.25, pp.25-100, 2013. ,
DOI : 10.1016/j.jacc.2013.10.033
Pulmonary hypertension in copd: Epidemiology, significance, and management: pulmonary vascular disease: the global perspective. Chest, pp.39-51, 2010. ,
Hypertension pulmonaire au cours des maladies respiratoires chroniques. Presse Médicale, pp.945-56, 2014. ,
DOI : 10.1016/j.lpm.2014.07.006
Surgical treatment of chronic thromboembolic pulmonary hypertension, European Respiratory Journal, vol.41, issue.3, pp.735-777, 2013. ,
DOI : 10.1183/09031936.00058112
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension, New England Journal of Medicine, vol.369, issue.4, pp.319-348, 2013. ,
DOI : 10.1056/NEJMoa1209657
Chronic post-embolic pulmonary hypertension: a new target for medical therapies?, European Respiratory Review, vol.22, issue.129, pp.258-64, 2009. ,
DOI : 10.1183/09059180.00003513
Traitement chirurgical de l'hypertension pulmonaire post-embolique. Presse Médicale, pp.994-1007, 2014. ,
DOI : 10.1016/j.lpm.2014.07.007
The pulmonary vascular complications of hereditary haemorrhagic telangiectasia, European Respiratory Journal, vol.33, issue.5, pp.1186-94, 2009. ,
DOI : 10.1183/09031936.00061308
Familial pulmonary hypertension and multiple abnormalities of large systemic arteries in Osler's disease, The American Journal of Medicine, vol.53, issue.1, pp.50-63, 1972. ,
DOI : 10.1016/0002-9343(72)90115-5
Echocardiographic screening discloses increased values of pulmonary artery systolic pressure in 9 of 68 unselected patients affected with hereditary hemorrhagic telangiectasia, Genetics in Medicine, vol.47, issue.3, pp.183-90, 2006. ,
DOI : 10.1203/00006450-200001000-00008
) Mutation, American Journal of Respiratory and Critical Care Medicine, vol.181, issue.8, pp.851-61, 2010. ,
DOI : 10.1161/01.CIR.0000154543.07679.08
Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia, Journal of Medical Genetics, vol.40, issue.12, pp.865-71, 2003. ,
DOI : 10.1136/jmg.40.12.865
Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic Telangiectasia, New England Journal of Medicine, vol.345, issue.5, pp.325-359, 2001. ,
DOI : 10.1056/NEJM200108023450503
Clinical and genetic characteristics of Chinese patients with hereditary haemorrhagic telangiectasia-associated pulmonary hypertension, European Journal of Clinical Investigation, vol.36, issue.Suppl 3, pp.1016-1040, 2013. ,
DOI : 10.1111/j.1365-2362.2006.01683.x
Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia, European Respiratory Journal, vol.23, issue.3, pp.373-380, 2004. ,
DOI : 10.1183/09031936.04.00085504
Transforming Growth Factor-? Receptor Mutations and Pulmonary Arterial Hypertension in Childhood. Circulation, pp.435-476, 2005. ,
DOI : 10.1161/01.cir.0000153798.78540.87
URL : http://circ.ahajournals.org/content/circulationaha/111/4/435.full.pdf
Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension, Thorax, vol.59, issue.5, pp.446-454, 2004. ,
DOI : 10.1136/thx.2003.11890
Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension. Hum Mutat, pp.1385-1394, 2011. ,
Bosentan therapy for pulmonary arterial hypertension associated with hereditary haemorrhagic telangiectasia, European Journal of Clinical Investigation, vol.36, issue.s3, pp.71-73, 2006. ,
DOI : 10.1183/09031936.05.00054804
Successful bosentan therapy for pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia. Heart Vessels, pp.231-235, 2011. ,
DOI : 10.1007/s00380-010-0079-z
Hereditary hemorrhagic telangiectasia, liver vascular malformations and cardiac consequences, European Journal of Internal Medicine, vol.24, issue.3, pp.35-44, 2013. ,
DOI : 10.1016/j.ejim.2012.12.013
Long?term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: A single?center study, Liver Transpl, vol.16, issue.3, pp.340-347, 2010. ,
The Intersection of Genes and Environment, Chest, vol.141, issue.6, pp.1598-600, 2012. ,
DOI : 10.1378/chest.11-1402
The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease, European Respiratory Journal, vol.41, issue.1, pp.217-240, 2013. ,
DOI : 10.1183/09031936.00074312
Doppler Ultrasonographic Grading of Hepatic Vascular Malformations in Hereditary Hemorrhagic Telangiectasia - Results of Extensive Screening, Ultraschall in der Medizin - European Journal of Ultrasound, vol.25, issue.05, 1980. ,
DOI : 10.1055/s-2004-813549
Echocardiography in Pulmonary Arterial Hypertension: from Diagnosis to Prognosis, Journal of the American Society of Echocardiography, vol.26, issue.1, pp.1-14, 2013. ,
DOI : 10.1016/j.echo.2012.10.009
Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study, Arthritis & Rheumatism, vol.351, issue.12, pp.3792-800, 2005. ,
DOI : 10.1164/ajrccm.164.2.2006129
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study, Annals of the Rheumatic Diseases, vol.65, issue.Suppl 1, pp.1340-1349 ,
DOI : 10.1002/art.37838
L???hypertension art??rielle pulmonaire associ??e au VIH, Revue des Maladies Respiratoires, vol.29, issue.4, pp.491-500 ,
DOI : 10.1016/j.rmr.2011.09.050
Prevalence of HIV-related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.1, pp.108-121, 2008. ,
DOI : 10.1016/j.ehj.2004.09.014
Pulmonary Hypertension in Sickle Cell Disease, Annals of the American Thoracic Society, vol.11, issue.9, pp.1488-1497, 2014. ,
DOI : 10.1001/jama.2012.358
Hemodynamic Characteristics and Predictors of Pulmonary Hypertension in Patients With Sickle Cell Disease, The American Journal of Cardiology, vol.109, issue.9, pp.1353-1360, 2012. ,
DOI : 10.1016/j.amjcard.2011.11.067
A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease, New England Journal of Medicine, vol.365, issue.1, pp.44-53, 2011. ,
DOI : 10.1056/NEJMoa1005565
URL : https://hal.archives-ouvertes.fr/inserm-00609555
Pulmonary hypertension associated with congenital heart disease and Eisenmenger syndrome]. Arch Cardiol México, pp.32-49, 2015. ,
Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease, Journal of Medical Genetics, vol.43, issue.2, pp.97-110, 2006. ,
DOI : 10.1136/jmg.2005.030833
Experience of the Irish National Centre for hereditary haemorrhagic telangiectasia, Respir Med, 2003. ,
Genotypephenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations, Am J Med Genet A, vol.140, issue.5, pp.463-70, 2006. ,
DOI : 10.1002/ajmg.a.31101